Danggui Shaoyao San Alleviates Early Cognitive Impairment in Alzheimer's Disease Mice Through IRS1/GSK3β/Wnt3a‐β‐Catenin Pathway
Brain and Behavior · 2024
DOI: 10.1002/brb3.70056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2024. Verfasst von Kai-Xin Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: First College of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Insulin Receptor Substrate Proteins, Drugs, Chinese Herbal, Glycogen Synthase Kinase 3 beta. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province, National Natural Science Foundation of China.
Themen: Demenz
Abstract (Originalsprache)
Introduction
Alzheimer's disease (AD) is a neurodegenerative disease characterized by Amyloid plaques and neurofibrillary tangles. We explored the potential mechanism by which Danggui Shaoyao San (DSS) modulates central glucose metabolism via the insulin receptor substrate 1 (IRS1)/glycogen synthase kinase‐3β (GSK3β)/Wnt3a‐β‐catenin pathway, thereby exerting protective effects on cognitive functions.
Methods
In vitro, HT22 cells were induced with streptozotocin (STZ) to investigate the impact of GSK3β on pathway transduction. The active components in the DSS stock solution were validated using mass spectrometry. Subsequently, an AD model in C57BL/6J mice was established through STZ injection into both ventricles. The success of the model was validated behaviorally and pathologically. The Morris Water Maze (MWM) test, immunohistochemistry, Western blotting, quantitative reverse transcription‐PCR, and 18F‐fluorodeoxyglucose‐positron emission tomography (FDG‐PET) were employed to evaluate the influence of DSS on memory and pathological changes in AD.
Results
The DSS stock solution, rich in active components, ameliorated the memory deficits in AD mice in the MWM. In vitro, GSK3β exhibited regulatory control over Wnt and β‐catenin, with GSK3β inhibition mitigating β‐amyloid and tau redundancies at protein and gene levels, facilitating signal transduction. In vivo, DSS impacted key targets in the IRS1/GSK3β/Wnt3a‐β‐catenin pathway, mitigated senile plaques resulting from amyloid β (Aβ) deposition and neurofiber tangles induced by tau hyperphosphorylation, and alleviated the decline in central glucose metabolism observed in FDG‐PET.
Conclusions
Our findings suggest that DSS potentially confers cognitive protection by alleviating central hypoglycemia through the IRS1/GSK3β/Wnt3a‐β‐catenin pathway. This may serve as a promising therapeutic avenue for AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- First College of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
- Beijing University of Chinese Medicine East Hospital, Zaozhuang Hospital, Zaozhuang, China.
- College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
- School of Acupuncture-Moxibustion and Tuina, Shandong University of Traditional Chinese Medicine, Jinan, China.
- Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
Förderung
- Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China
Zitieren
APA
Zhang, K. X., Sheng, N., Ding, P. L., Zhang, J. W., Xu, X. Q., & Wang, Y. H. (2024). Danggui Shaoyao San Alleviates Early Cognitive Impairment in Alzheimer's Disease Mice Through IRS1/GSK3β/Wnt3a‐β‐Catenin Pathway. Brain and Behavior. https://doi.org/10.1002/brb3.70056
Vancouver
Zhang KX, Sheng N, Ding PL, Zhang JW, Xu XQ, Wang YH. Danggui Shaoyao San Alleviates Early Cognitive Impairment in Alzheimer's Disease Mice Through IRS1/GSK3β/Wnt3a‐β‐Catenin Pathway. Brain and Behavior. 2024. doi:10.1002/brb3.70056
BibTeX
@article{Zhang2024,
author = {Zhang, Kai-Xin and Sheng, Ning and Ding, Peng-Li and Zhang, Ji-Wei and Xu, Xiang-Qing and Wang, Ya-Han},
title = {Danggui Shaoyao San Alleviates Early Cognitive Impairment in Alzheimer's Disease Mice Through IRS1/GSK3β/Wnt3a‐β‐Catenin Pathway},
journal = {Brain and Behavior},
year = {2024},
doi = {10.1002/brb3.70056}
}
EUVIMED